{
      "brief_title": [
            "tarceva",
            "plus",
            "gemcitabine",
            "patient",
            "locally",
            "advance",
            "unresectable",
            "metastatic",
            "pancreatic",
            "cancer"
      ],
      "brief_summary": [
            "purpose",
            "study",
            "determine",
            "improve",
            "overall",
            "survival",
            "combine",
            "standard",
            "dose",
            "chemotherapy",
            "drug",
            "gemcitabine",
            "individual",
            "pancreatic",
            "cancer"
      ],
      "condition": [
            "cancer"
      ],
      "intervention_type": [
            "Drug"
      ],
      "intervention_name": [
            "Tarceva (erlotinib HCl, OSI-774)"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "histologically",
            "cytologically",
            "confirm",
            "diagnosis",
            "adenocarcinoma",
            "pancreas",
            "cancer",
            "unresectable",
            "locally",
            "advance",
            "metastatic",
            "must",
            "evidence",
            "disease",
            "clinical",
            "radiological",
            "male",
            "female",
            "18",
            "year",
            "older",
            "patient",
            "may",
            "receive",
            "prior",
            "radiation",
            "treatment",
            "management",
            "local",
            "disease",
            "provide",
            "disease",
            "progression",
            "document",
            "toxicity",
            "resolve",
            "last",
            "fraction",
            "radiation",
            "treatment",
            "complete",
            "least",
            "4",
            "week",
            "prior",
            "randomization",
            "patient",
            "may",
            "receive",
            "prior",
            "chemotherapy",
            "folic",
            "acid",
            "gemcitabine",
            "give",
            "concurrently",
            "radiation",
            "treatment"
      ],
      "gender": "All",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "keyword": [
            "tarceva",
            "egfr",
            "erlotinib"
      ],
      "mesh_term": [
            "neoplasm",
            "hydrochloride"
      ],
      "id": "NCT00040183"
}